ibopamine has been researched along with Cardiac Output, Low in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boomsma, F; Brouwer, J; Dunselman, PH; Lie, KI; Man in 't Veld, AJ; van Veldhuisen, DJ | 1 |
| Buikema, H; de Graeff, PA; de Smet, BJ; Girbes, AR; Lie, KI; Scholtens, E; van Gilst, WH; van Veldhuisen, DJ; Wesseling, H | 1 |
1 trial(s) available for ibopamine and Cardiac Output, Low
| Article | Year |
|---|---|
Progression of mild untreated heart failure during six months follow-up and clinical and neurohumoral effects of ibopamine and digoxin as monotherapy. DIMT Study Group. Dutch Ibopamine Multicenter Trial.
Topics: Adolescent; Adult; Aged; Cardiac Output, Low; Cardiotonic Agents; Deoxyepinephrine; Digoxin; Disease Progression; Dopamine Agonists; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Netherlands; Neurotransmitter Agents; Norepinephrine; Physical Exertion; Placebos; Renin; Stroke Volume; Ventricular Function, Left | 1995 |
1 other study(ies) available for ibopamine and Cardiac Output, Low
| Article | Year |
|---|---|
Neurohumoral and hemodynamic effects of ibopamine in a rat model of chronic myocardial infarction and heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiac Output, Low; Chronic Disease; Deoxyepinephrine; Disease Models, Animal; Dopamine Agonists; Hemodynamics; Male; Myocardial Infarction; Myocardium; Neurotransmitter Agents; Peptidyl-Dipeptidase A; Rats; Rats, Wistar | 1994 |